{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:12:26Z","timestamp":1794492746382,"version":"4.9.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24wm0125002"],"award-info":[{"award-number":["JP24wm0125002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP243fa627001"],"award-info":[{"award-number":["JP243fa627001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24fk0108626"],"award-info":[{"award-number":["JP24fk0108626"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-60791-5","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T10:48:35Z","timestamp":1750416515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy of baloxavir marboxil against bovine H5N1 virus in mice"],"prefix":"10.1038","volume":"16","author":[{"given":"Maki","family":"Kiso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-1922","authenticated-orcid":false,"given":"Ryuta","family":"Uraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5157","authenticated-orcid":false,"given":"Seiya","family":"Yamayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-8296","authenticated-orcid":false,"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"60791_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-024-07849-4","volume":"634","author":"LC Caserta","year":"2024","unstructured":"Caserta, L. C. et al. Spillover of highly pathogenic avian influenza H5N1 virus to dairy cattle. Nature 634, 669\u2013676 (2024).","journal-title":"Nature"},{"key":"60791_CR2","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1056\/NEJMc2405371","volume":"390","author":"TM Uyeki","year":"2024","unstructured":"Uyeki, T. M. et al. Highly Pathogenic Avian Influenza A(H5N1) virus infection in a dairy farm worker. N. Engl. J. Med. 390, 2028\u20132029 (2024).","journal-title":"N. Engl. J. Med."},{"key":"60791_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.100978","volume":"5","author":"P Venkatesan","year":"2024","unstructured":"Venkatesan, P. Human cases of avian influenza A(H5) in the USA. Lancet Microbe 5, 100978 (2024).","journal-title":"Lancet Microbe"},{"key":"60791_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-024-07766-6","volume":"633","author":"AJ Eisfeld","year":"2024","unstructured":"Eisfeld, A. J. et al. Pathogenicity and transmissibility of bovine H5N1 influenza virus. Nature 633, 426\u2013432 (2024).","journal-title":"Nature"},{"key":"60791_CR5","doi-asserted-by":"publisher","unstructured":"Gu, C. et al. A human isolate of bovine H5N1 is transmissible and lethal in animal models. Nature. https:\/\/doi.org\/10.1038\/s41586-024-08254-7 (2024).","DOI":"10.1038\/s41586-024-08254-7"},{"key":"60791_CR6","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","volume":"96","author":"G Neumann","year":"1999","unstructured":"Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96, 9345\u20139350 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"60791_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/jac\/dkaa393","volume":"76","author":"Y Ando","year":"2021","unstructured":"Ando, Y. et al. Pharmacokinetic and pharmacodynamic analysis of baloxavir marboxil, a novel cap-dependent endonuclease inhibitor, in a murine model of influenza virus infection. J. Antimicrob. Chemother. 76, 189\u2013198 (2021).","journal-title":"J. Antimicrob. Chemother."},{"key":"60791_CR8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/jac\/dky462","volume":"74","author":"K Fukao","year":"2019","unstructured":"Fukao, K. et al. Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection. J. Antimicrob. Chemother. 74, 654\u2013662 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"60791_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.antiviral.2018.10.008","volume":"160","author":"T Noshi","year":"2018","unstructured":"Noshi, T. et al. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit. Antivir. Res. 160, 109\u2013117 (2018).","journal-title":"Antivir. Res."},{"key":"60791_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27890-4","volume":"8","author":"S Omoto","year":"2018","unstructured":"Omoto, S. et al. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Sci. Rep. 8, 9633 (2018).","journal-title":"Sci. Rep."},{"key":"60791_CR11","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3201\/eid2511.190757","volume":"25","author":"E Takashita","year":"2019","unstructured":"Takashita, E. et al. Human-to-Human Transmission of Influenza A(H3N2) virus with reduced susceptibility to Baloxavir, Japan, February 2019. Emerg. Infect. Dis. 25, 2108\u20132111 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"60791_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/gch2.1018","volume":"1","author":"S Elbe","year":"2017","unstructured":"Elbe, S. & Buckland-Merrett, G. Data, disease and diplomacy: GISAID\u2019s innovative contribution to global health. Glob. Chall. 1, 33\u201346 (2017).","journal-title":"Glob. Chall."},{"key":"60791_CR13","doi-asserted-by":"publisher","first-page":"10309","DOI":"10.1128\/JVI.01109-09","volume":"83","author":"B Zhou","year":"2009","unstructured":"Zhou, B. et al. Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza A viruses. J. Virol. 83, 10309\u201310313 (2009).","journal-title":"J. Virol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60791-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60791-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60791-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T10:48:36Z","timestamp":1750416516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60791-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60791"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60791-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"6 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.K. has received unrelated\u00a0grant support from Daiichi Sankyo\u00a0Co., Ltd., Fujifilm\u00a0Toyama Chemical Co., Ltd., Tauns Laboratories, Inc., Shionogi & Co. Ltd., Otsuka Pharmaceutical Co., Ltd., KM Biologics Co. Ltd., Kyoritsu Seiyaku\u00a0Corporation, Shinya Corporation and Fuji Rebio, Inc. Y.K. is a co-founder of FluGen. The other authors do not have any competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5356"}}